Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

#RemoteDetailing

- PMLiVE

Servier faces manslaughter trial over weight loss drug deaths

Drug shown to damage heart and thought to cause death

- PMLiVE

Want to know if you’re dehydrated? There’s an app for that.

Water water everywhere..but are we drinking it?

Page & Page Health

- PMLiVE

Astellas’ Xospata scores positive CHMP recommendation

Could become a potential option for hard-to-treat leukaemia

- PMLiVE

Labour party plans to abolish NHS prescription charges

Comes amid increased focus on drug pricing in the US

- PMLiVE

European biotech: a new generation of leaders emerges

Three companies that are on the rise in biotech

- PMLiVE

France’s Innate Pharma eyes $100m Nasdaq IPO

Would help fund development of antibody-based immunotherapies

- PMLiVE

Novo Nordisk gets FDA okay for new diabetes hope

Potential to combat increasing competition and pricing pressures

- PMLiVE

Q&A: Chris McPherson

PME interviews ENGINE | MHP's account director, health

- PMLiVE

Half of European cancer drug trials ‘biased’, says BMJ

Report says studies exaggerate benefits

- PMLiVE

Four Health and ARK among winners at PM Society Digital Awards

The awards celebrated its 10th year with biggest event yet

- PMLiVE

Democrats’ final pricing plan announced, 250 drugs targeted

Would allow US federal government to negotiate prices of key medicines

- PMLiVE

Insys gets bankruptcy court okay for Subsys sale

Opioid product was focus of racketeering charges

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links